Table 2:
SBRT location – no. (%) | Cohort A1 8Gy × 1 +Durva (N=14) |
Cohort A2 5Gy × 5 +Durva (N=10) |
Cohort B1 8Gy × 1 +Durva/Treme (N=19) |
Cohort B2 5Gy × 5 +Durva/Trem (N=16) |
---|---|---|---|---|
Pancreas | 14 (100) | 8 (80) | 9 (47) | 13 (81) |
Liver | 0 (0) | 1 (10) | 9 (47) | 2 (13) |
Peritoneum lesions | 0 (0) | 1 (10) | 1 (5) | 1 (6) |
Abbreviation: SBRT: stereotactic body radiation therapy; Durva: Durvalumab; Treme: Tremelimumab